Research Article - (2019) Volume 10, Issue 6
Real-World Evidence for the Tolerance and Effectiveness of the First Drug (Sacubitril/Valsartan) in a New Class-ARN in Afro-Caribbean Patients with Heart Failure with Reduced Ejection Fraction
- Felix Nunura1*, Edwin Tulloch-Reid2, Daniel Nepaul3, Dainia S Baugh3 and Ernest C Madu1
- 1Division of Cardiovascular Medicine, Heart Institute of the Caribbean, Kingston, Jamaica
- 2Department of Interventional Cardiology, Heart Institute of the Caribbean, Kingston, Jamaica
- 3Department of Medicine, Heart Institute of the Caribbean, Kingston, Jamaica
*Corresponding Author:
Felix Nunura, Division of Cardiovascular Medicine, Heart Institute of the Caribbean, Kingston, Jamaica, Tel: +18769062105
Email: